Diagnosis of ventilator-associated pneumonia: Is there a gold standard and a simple approach?

Current Opinion in Infectious Diseases

Volumn 21, Issue 2, 2008, Pages 174-178

  Lisboa, Thiago ^a   Rello, Jordi ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Biomarkers; Diagnosis; Microbiological diagnosis; Ventilator associated pneumonia

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

BACTERIUM CULTURE; BAYES THEOREM; FEVER; GOLD STANDARD; HUMAN; LEUKOCYTOSIS; NOSE SECRETION; PROBABILITY; REVIEW; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; HUMANS; PNEUMONIA, VENTILATOR-ASSOCIATED; TREATMENT OUTCOME; VENTILATORS, MECHANICAL;

EID: 43149090266     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3282f55dd1     Document Type: Review

References (38)

1. Sandiumenge A, Diaz E, Rodriguez A, et al. Impact of diversity of antibiotic use on the development of antimicrobial resistance. J Antimicrob Chemother 2006; 57:1197-1204.
2. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122:2115-2121.
3. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of healthcare associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128:3854-3862.
4. US Centers for Disease Control: CDC definitions for nosocomial infections 1988. Am Rev Respir Dis 1989; 139:1058-1059.
5. Klompas M. Does this patient have ventilator-associated pneumonia? JAMA 2007; 297:1583-1593. This is an excellent systematic review of clinical criteria for VAP diagnosis.
6. Gallego M, Rello J. Diagnostic testing for ventilator-associated pneumonia. Clin Chest Med 1999; 20:671-679.
7. El Solh AA, Akinnusi ME, Pineda LA, Mankowski CR. Diagnostic yield of quantitative endotracheal aspirates in patients with severe nursing-home acquired pneumonia. Crit Care 2007; 11:R57.
8. Hayon J, Figliolini C, Combes A, et al. Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:41-46.
9. Wu CL, Yang DI, Wang NY, et al. Quantitative culture of endotracheal aspirates in the diagnosis of ventilator-associated pneumonia in patients with treatment failure. Chest 2002; 122:662-668.
10. American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
11. Lisboa T, Rello J. The simple and the simpler in pneumonia diagnosis. Crit Care 2007; 11:140. This editorial discusses the validity of using rigid breakpoints for VAP diagnosis in the absence of a gold standard for comparison.
12. Michaud S, Suzuki S, Harbarth S. Effect of design-related bias in studies of diagnostic tests for ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 166:1320-1325.
13. Niederman MS. Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms. Clin Infect Dis 2006; 42 (Suppl 2):S72-S81. This is an excellent review that addresses questions regarding empirical treatment of VAP patients to optimize outcomes and avoid emergence of antimicrobial resistance in critically ill patients.
14. Pugin J, Auckenthaler R, Mili N, et al. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic 'blind' bronchoalveolar lavage fluid. Am Rev Respir Dis 1991; 143:1121-1129.
15. Singh N, Rogers P, AtwoodCW, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000; 162:505-511.
16. Schurink CA, Visscher SA, Lucas PJ, et al. A Bayesian decision-support system for diagnosing ventilator-associated pneumonia. Intensive Care Med 2007; 33:1379-1386. This report describes the use of a computerized system that integrates data to obtain a more objective VAP diagnosis.
17. Gibot S, Cravoisy A, Levy B, et al. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004; 350:451-458.
18. Horonenko G, Hoyt JC, Robbins RA, et al. Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report. Chest 2007; 132:58-63.
19. Soto GJ. Diagnostic strategies for nosocomial pneumonia. Curr Opin Pulm Med 2007; 13:186-191. This is an interesting review of diagnostic strategies for nosocomial pneumonia, placing emphasis on utilization of biomarkers.
20. Chastre J, Luyt CE, Trouillet JL, Combes A. New diagnostic and prognostic markers of ventilator-associated pneumonia. Curr Opin Crit Care 2006; 12:446-451.
21. Stolz D, Christ-Crain M, Bingisser R, et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 2007; 131:9-19.
22. Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006; 174:84-93.
23. Seligman R, Meisner M, Lisboa T, et al. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 2006; 10:R125.
24. Luyt CE, Guerin V, Combes A, et al. Procalcitonin kinetics as a prognositc marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 2005; 171:48-53.
25. Oppert M, Reinicke A, Muller C, et al. Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation. Resuscitation 2002; 53:167-170.
26. Ramirez P, Garcia MA, Ferrer M, et al. Sequential measurements of procalcitonin in diagnosing ventilator-associated pneumonia. Eur Respir J 2007; 24 Oct [Epub ahead of print].
27. Brunckhorst FM, Al-Nawas B, Krummenauer F, et al. Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia. Clin Microbiol Infect 2002; 8:93-100.
28. Povoa P, Coelho L, Almeida E, et al. C-reactive protein as a marker of ventilator-associated pneumonia. Eur Respir J 2005; 25:804-812.
29. Lisboa T, Seligman R, Diaz E, et al. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia. Crit Care Med 2008, 36:166-171. It describes use of CRP level variation as a marker of appropriate empirical treatment in clinically diagnosed VAP patients.
30. Bahrani-Mougeot FK, Paster BJ, Coleman S, et al. Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia. J Clin Microbiol 2007; 45:1588-1593. This report discusses the limitations of conventional microbiological identification techniques and describes unidentified pathogens that might be associated with VAP episodes, isolated using a PCR technique.
31. Bouza E, Torres MV, Radice C, et al. Direct E-test (AB Biodisk) of respiratory samples improves antimicrobial use in ventilator-associated pneumonia. Clin Infect Dis 2007; 44:382-387. This report describes the use of antimicrobial sensitivity test directly in respiratory samples from patients with suspected VAP.
32. Sole-Violan J, Fernandez JA, Benitez AB, et al. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med 2000; 28:2737-2741.
33. Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial. Ann Intern Med 2000; 132:621-630.
34. Raghavendran K, Wang J, Belber C, et al. Predictive value of sputum Gram stain for the determination of appropriate antibiotic therapy in ventilator-associated pneumonia. J Trauma 2007; 62:1377-1382.
35. The Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006; 355:2619-2630. This randomized, clinical trial compared an invasive with a noninvasive diagnostic approach in VAP. It found no difference in mortality, antibiotic use, or de-escalation rate between the two approaches.
36. Rello J, Vidaur L, Sandiumenge A, et al. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 2004; 32:2183-2190.
37. Giantsou E, Liratzopoulos N, Efraimidou E, et al. De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate. Intensive Care Med 2007; 33:1533-1540.
38. Michel F, Franceschini B, Berger P, et al. Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest 2005; 127:597-697.